Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Biomedizinische Technik. Biomedical Engineering
|
May 18, 2010
On the role of cost-sensitive learning in multi-class brain-computer interfaces
Dieter Devlaminck, Willem Waegeman, Bart Wyns, et al.
Computational Intelligence and Neuroscience
|
October 19, 2011
Multisubject learning for common spatial patterns in motor-imagery BCI
Dieter Devlaminck, Bart Wyns, Moritz Grosse-Wentrup, et al.
Arthritis and Rheumatism
|
October 1, 2004
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients
Dominique Baeten, Elli Kruithof, Leen De Rycke, et al.
Arthritis Research & Therapy
|
September 19, 2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Arthritis Research & Therapy
|
October 7, 2005
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Biomedizinische Technik. Biomedical Engineering
|
May 18, 2010
On the role of cost-sensitive learning in multi-class brain-computer interfaces
Dieter Devlaminck, Willem Waegeman, Bart Wyns, et al.
Computational Intelligence and Neuroscience
|
October 19, 2011
Multisubject learning for common spatial patterns in motor-imagery BCI
Dieter Devlaminck, Bart Wyns, Moritz Grosse-Wentrup, et al.
Arthritis and Rheumatism
|
October 1, 2004
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients
Dominique Baeten, Elli Kruithof, Leen De Rycke, et al.
Arthritis Research & Therapy
|
September 19, 2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Arthritis Research & Therapy
|
October 7, 2005
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Page
of 1